Enjoying this newsletter? Why not share it with a friend? Covid-19 vaccine license change: 12 key questions answeredAnd an important note about the ousted CDC leaders
A few hours ago, RFK Jr. ousted the CDC Director for refusing to rubber-stamp unscientific and reckless directives. In its wake, three senior CDC officials also resigned. The United States lost remarkable leaders today—people who devoted decades, across many administrations, to protecting the health of families and communities. They weren’t just experts; they were steady hands and trusted voices, showing up in moments of crisis with clarity, compassion, and an unwavering commitment to the public good. When leaders like this are pushed out, it’s not just the agency that suffers; it’s all of us. A weaker CDC means more vulnerable communities. Public health only works when the people leading it are strong, principled, and supported in their duty to protect and serve individuals and communities. Right now, that foundation is eroding at a speed I never thought possible. The nation’s health security is at risk. Thank you for your service, Dimetre, Dan, Deb, and Susan. I’m beyond heartbroken by what is happening at CDC and the public health field as a whole. Simply put: This is not okay. Now, for Covid-19 vaccine news… At CVS the other day, a pregnant woman—glowing, excited for her first baby—stepped up to the counter and asked for the Covid-19 vaccine. She knew the shot could pass antibodies to her newborn, protecting during those fragile first months of life. The most basic human instinct: a mother protecting her child. But the pharmacist shook his head. “We have no idea what’s happening. The guidelines keep changing. We can’t give you a vaccine.” Tears welled up as she asked for the older Covid-19 vaccine formula. Again, no. She walked out without the protection she came for. I wish I could have answered all of her questions (and the pharmacists!) right there in that moment. Instead, I’m hoping to equip you with the clarity she—and so many others—deserve. This scene is likely repeating across the country. Here are the top 12 questions we got from you, answered with what I know today. 1. Who is eligible for the Covid-19 vaccine this fall?This is a simple question with a complicated answer, as it depends on whom you want to turn to for guidance. The federal government (FDA) changed the license (i.e., “label”) for the Covid-19 vaccine today (August 27). FDA’s job is to determine whether a vaccine is safe, effective, and properly manufactured. So each year, before fall vaccines go in arms, the FDA updates the fall vaccine labels after inspecting production and before they reach shelves. The FDA announced that the Covid-19 vaccine is ready for use, but it has limited the vaccine label to individuals over 65 and those between 16 and 64 years old with at least one condition that puts them at high risk for severe outcomes from Covid-19. This is different from previous years, when it was labeled for everyone over 6 months. It is highly unusual for the FDA to restrict its approval for a drug in this way. Regardless, last week, professional organizations started releasing their own recommendations (which they’ve done for more than 90 years), and some do not align with FDA’s new label:
To make things even more confusing, the federal government will weigh in again this September through ACIP—an external advisory committee to the CDC that sets vaccine policy—on who they believe should receive the Covid-19 vaccine. Typically, this guidance is issued in June (before the license change), so this delay is unusual and leaves insurance companies uncertain about who should be covered. Bottom line: If someone is not within the FDA label (for example, a healthy 1-year-old) but still wants the Covid-19 vaccine this fall (for example, because AAP recommends it), they will need to get the Covid-19 vaccine “off-label.” 2. What qualifies as high risk?“High risk” appears undefined by the FDA. This is normal and indicates that it defaults to this CDC review, which remains unchanged from earlier this year. CDC’s “high risk” list covers a significant portion of the U.S. adult population, including pregnant people and people with diabetes, a disability, overweight/obesity, cancer, or a mental health condition. This list could (and likely will) be changed in September during the ACIP meeting by the committee that RFK Jr. replaced. We will update you if that happens. 3. Will we need documentation to prove we’re “at risk?”Pharmacies will likely go with something called “self-attestation.” In other words, you need to check a box that says you have a high-risk condition. It’s unlikely that insurance will check this against your medical records, but it’s possible. 4. If I’m not high risk, can I get the vaccine off-label? Could I pay out of pocket if I want it?It will likely be hard to get it “off-label,” but not impossible. There are three reasons for this:
5. What about physician liability?Despite what RFK Jr. has implied in the most heinous way, doctors are not suddenly at risk for doing their jobs if they follow AAP or ACOG guidance. Prescribing off-label happens every day in medicine. One in five medications is prescribed off-label. The FDA label change may impact the additional liability immunity provided by the PREP Act for use of Covid-19 vaccines. Regardless, providers are covered by the same professional liability and malpractice standards that apply to their other medical decisions. Physicians remain free to recommend what they believe is best for their patients. 6. When should I get the Covid-19 vaccine?Technically, you can get it right now. However, please note that it may take a few days to a week for your pharmacy to receive the new vaccine shipment. If you have recently had a Covid-19 infection, it’s best to wait at least 6 months. If you’re at high risk and more than 6 months have passed since your last vaccine, I recommend getting the vaccine now. This will help protect you against severe disease, and we are in the middle of a Covid-19 wave. 7. What is happening with the pediatric vaccine?Pfizer will not have a vaccine for children under 5. But Moderna will. As a result, the supply may be more limited, but technically, a vaccine is still available for this age group. Specifically:
8. Is the vaccine formula being updated this year?Yes, to better match the variants currently circulating. 9. Is it okay not to get the Covid-19 vaccine anymore? Does having had a vax + some boosters provide any long-term protection? For how long?The science hasn’t changed: The vaccine is still safe and effective. What has changed is the environment: most of us now have some level of immunity, which is why Covid-19 is no longer an emergency. Immunity has two layers: short-term antibodies and long-term memory cells (T cells). Covid-19 antibodies fade within about 4 months, so without a recent vaccine (or infection), you’re more likely to get infected and more likely to spread it to others. Memory cells last longer and help prevent severe illness—this doesn’t seem to fade for healthy or young individuals, but not everyone’s immune system holds onto that protection equally well. That’s why high-risk groups are prioritized for ongoing vaccinations, like pregnant women, children under 2, adults over 65, and those with chronic conditions. 10. Does this situation apply to all brands of vaccines?Yes. mRNA vaccines (Pfizer, Moderna) and the protein vaccine (Novavax) are all part of the same regulatory and policy tangle. 11. What will you be doing?For my family, I will look to medical societies whose recommendations are evidence-based, trustworthy, and consistent. 12. What should I do right now?Consider getting vaccinated for Covid-19 this fall. People who meet the new label indications should seek vaccines in ways similar to past years—through a pharmacist, physician, nurse, or other health care provider. For those who aren’t within the label:
If you have trouble finding a vaccine and want to share your story, fill out this YLE form. We can’t help you find a store, but we would like to hear your story and share it with others, if you’re comfortable with it. Bottom lineToday, the FDA changed the Covid-19 label, but the good news is that the high-risk list is still broad for now, and an off-label vaccination is possible. Many professional organizations are stepping in to recommend what the scientific evidence supports. Love, YLE Your Local Epidemiologist (YLE) is founded and operated by Dr. Katelyn Jetelina, MPH PhD—an epidemiologist, wife. YLE is a public health newsletter that reaches over 380,000 people in more than 132 countries, with one goal: to translate the ever-evolving public health science so that people are well-equipped to make evidence-based decisions. This newsletter is free to everyone, thanks to the generous support of fellow YLE community members. To support the effort, subscribe or upgrade below: |
PRESIDENT GREEN LIGHTS NEW PENN STATION CONSTRUCTION. NEW DESIGNS SOUGHT.
NEW TRANSIT HEAD REQUESTS DESIGN PROPOSALS

THE CLASSIC PENN STATION 1910


Moynihan Train Hall interior eerily reminiscent of the original Penn Station
OPENED 2021 $1.6 Billion Cost

CONCOURSE TODAY
STATEMENT ON THE NEW PENN STATION FROM GOVERNOR KATHY HOCHUL
“One of the first things I raised with President Trump in January was the need to give New York City the beautiful Penn Station it deserves. Those conversations successfully secured federal funding in April to advance redevelopment, allowing us to reallocate over $1 billion for other critical projects. With Secretary Duffy now advancing this project and requesting design proposals, New Yorkers are one step closer to a station worthy of this great city.”
Wednesday the Transportation Secretary Sean Duffy announced the project would cost $7 Billion and begin construction in 2027.
UPDATED:
The Moynihan Hall (the present concourse) was opened 14 years ago in January of 2021 at a construction cost of $1.6 Billion. This hall will be completely be redesigned.
The Gateway Development Commission is currently constructing 2 new railway tunnels another project greenlighted by the President. This is expected to double the number of trains to come into the new station.
In an article today, Mr. Duffy was reported by the New York Times to have said he could not estimate the total cost of the project.
Duffy also, The Times reported, asked if the station would be renamed, quipped when asked what the name might be said, “(Trump Station) has a nice ring to it.”
AUGUST 27–GOVERNOR HOCHUL SIGNS ANTI DISCRIMINATION LAW
GOVERNOR HOCHUL SIGNS LANDMARK LEGISLATION TO PROTECT STUDENTS AGAINST DISCRIMINATION AND BOLSTER CAMPUS SAFETY
Title VI Coordinators Mandated on All New York College Campuses
In Coordination With New York State Anti-Hate in Education Center Launched in 2023
Governor Hochul WEDNESDAY signed landmark legislation to require Title VI anti-discrimination coordinators on every New York college campus.
Coordinators will work hand-in-hand with students, faculty, and staff to confront discrimination on campus as part of the Governor’s longstanding commitment to promote a safe learning environment for all students in New York’s higher education institutions. This important step forward continues the Governor’s ongoing efforts to combat racial bias, antisemitism and any form of bigotry on college campuses throughout New York.
“By placing Title VI coordinators on all college campuses, New York is combating antisemitism and all forms of discrimination head-on,” Governor Hochul said. “No one should fear for their safety while trying to get an education. It’s my top priority to ensure every New York student feels safe at school, and I will continue to take action against campus discrimination and use every tool at my disposal to eliminate hate and bias from our school communities.”
By mandating Title VI coordinators on all New York college campuses, Governor Hochul is leading the nation in protecting students. The New York State Division of Human Rights will develop training to ensure colleges and universities have the tools they need to uphold the protections of Title VI of the Civil Rights Act of 1964. Title VI prohibits discrimination on the basis of race, color, or national origin, including shared ancestry or ethnic characteristics.
The Governor’s Title VI legislation is the latest in a string of actions she’s taken to foster an inclusive learning environment on campus. In 2023, she established the New York State Anti-Hate in Education Center to study, address, and eradicate all forms of campus discrimination. She also directed the state to bolster its hate crime data collection process, made record investments in physical security at vulnerable sites, established a domestic terrorism prevention unit, and conducted a thorough review of state-funded universities’ policies related to discrimination.
State Senator Toby Ann Stavisky said, “I am delighted that the Governor is signing landmark legislation that we have passed to protect students from discrimination on our campuses. At a time when we see a troubling rise in hate crimes, New York is taking a clear stand. Too many students’ experiencing discrimination do not know where to go for help or what protections they are entitled to, and everyone has a right to feel safe when they step onto college campuses. Dignity, safety and equal opportunity are not negotiable. I thank Governor Hochul and her staff, Assemblywoman Nily Rozic, and advocates and student leaders for making an idea into a reality.”
State Senator Shelley B. Mayer said, “Every student, regardless of gender, race, sexual orientation, religion or any other characteristic, deserves a fair chance to succeed and to receive higher education without fear and intimidation. As our country faces increased instances of hate, particularly antisemitism, our colleges must take proactive measures to ensure everyone feels safe and welcome on campuses. The appointment of a designated Title VI Coordinator ensures that when violations occur students have clear points of contact and the colleges and universities have clear paths for corrective action, with a dedicated person responsible. This legislation reaffirms our commitment to dismantling barriers and ensuring personal security while attending colleges or universities in New York. I am deeply grateful to my colleagues Senator Toby Stavisky and Assembly Member Nily Rozic for carrying this legislation and Governor Kathy Hochul for signing it into law.”
State Senator Robert Jackson said, “As a proud co-sponsor of this legislation, I know what this bill means for students across New York. Title VI of the Civil Rights Act promised equal access to education — but rights only matter when they are enforced. By requiring every college and university to appoint a Title VI coordinator, we’re ensuring that promise has both oversight and impact. I thank Governor Hochul for signing this bill into law and standing with us. Together, we are sending a clear message: discrimination has no place on our campuses, and equity is not optional — it is the law.”
AUGUST 26– HOUSING PRICES REMAIN HIGH. SIGNS MARKET IS STABILIZING
- Mortgage Rates: With 30-year mortgage rates averaging around 7% in July, many buyers remain cautious. Still, the Hudson Valley continues to attract those seeking space, value, and proximity to New York City.
- Shift in Buyer Behavior: Increased exploration of co-ops, condos, and townhomes continues, as affordability remains top of mind.
- Luxury vs. Entry-Level: Homes under $500,000 are still moving quickly, while higher-end properties are lingering longer and often require strategic pricing and staging.
- Inventory and Leverage:
- Inventory levels remain below the 6-9 months considered balanced. Markets like the Bronx, now at over 7 months of inventory, are offering buyers more negotiating room, while counties like Westchester and Rockland remain seller-favored.
- The median single-family home price hit $1,500,000 (+11% YoY).
- Closed sales were up 4%, while new listings dropped 6%.
- Days on market dropped to 18, down 5%, and months of inventory remained tight at 2.5.
- Condo prices rose 1%, co-ops 5%. Condos saw a decline in closed sales by 11% while co-op closed sales were up 2%.
- Median price increased to $565K (+11%).
- Closed sales were up 16%.
- Inventory rose to 3.3 months, and days on market were up 4% to 26.
- Condo prices rose to $387K, up 9%.
- Single-family median price: $765,000 (+17%).
- Closed sales were up slightly (+2%), but co-op sales dropped by 40%.
- Inventory sits at 3.2 months.
- New listings up 11%, but days on market dropped to 19 almost 10%.
- Median price reached $460,000 (+2.2%).
- Closed sales were up 4%.
- Inventory at 4.1 months with 405 new listings.
- Days on market rose to 31.
- Median price rose to $468,000 (+9.5%).
- Co-ops remain in high demand, up 6.7% in median price.
- Closed sales were down 16%, and new listings dropped slightly by 1.7%.
- Inventory at 7.6 months offers more negotiating power for buyers.
